212 related articles for article (PubMed ID: 9866538)
1. Alternate routes of administration.
West VL
J Intraven Nurs; 1998; 21(4):221-31. PubMed ID: 9866538
[TBL] [Abstract][Full Text] [Related]
2. Safe, simple subcutaneous fluid administration.
Farrand S; Campbell AJ
Br J Hosp Med; 1996 Jun 5-18; 55(11):690-2. PubMed ID: 8793132
[TBL] [Abstract][Full Text] [Related]
3. [Subcutaneous drug administration. Indications for the use in terminal patients].
Postigo Mota S; Llerena Ruiz A; Lavado García JM; Norberto Gamero MJ; Durán Gómez N
Rev Enferm; 1999 Dec; 22(12):887-90. PubMed ID: 10797775
[TBL] [Abstract][Full Text] [Related]
4. The use of syringe drivers in palliative care.
Gomez Y
Aust Nurs J; 2000 Aug; 8(2):suppl 1-3. PubMed ID: 11894458
[No Abstract] [Full Text] [Related]
5. Intraosseous infusion.
Miccolo MA
Crit Care Nurse; 1990; 10(10):35-47. PubMed ID: 2249463
[TBL] [Abstract][Full Text] [Related]
6. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
Marin K; Oleszewski K; Muehlbauer P
Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
[TBL] [Abstract][Full Text] [Related]
7. The benefits of hypodermoclysis.
Donnelly M
Nurs Stand; 1999 Sep 15-21; 13(52):44-5. PubMed ID: 10693512
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous drug infusions: a review of problems and solutions.
Mitten T
Int J Palliat Nurs; 2001 Feb; 7(2):75-85. PubMed ID: 12271253
[TBL] [Abstract][Full Text] [Related]
9. Intraosseous infusions.
Tidwell B; Parks BR
Pediatr Nurs; 1991; 17(1):56-7. PubMed ID: 2000242
[No Abstract] [Full Text] [Related]
10. [Local adverse reactions associated with parenteral administration of drugs].
Bjånes TK
Tidsskr Nor Laegeforen; 2011 Mar; 131(5):472-4. PubMed ID: 21383802
[TBL] [Abstract][Full Text] [Related]
11. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
Hydzik C
Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
[TBL] [Abstract][Full Text] [Related]
12. Intravenous administration of medications to the pediatric patient.
Leff RD
NITA; 1983; 6(4):255-8. PubMed ID: 6555599
[No Abstract] [Full Text] [Related]
13. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
14. Hypodermoclysis. Another way to replace fluids.
Brown MK; Worobec F
Nursing; 2000 May; 30(5):58-9. PubMed ID: 10855196
[No Abstract] [Full Text] [Related]
15. Hypodermoclysis: an alternate method for rehydration in long-term care.
Walsh G
J Infus Nurs; 2005; 28(2):123-9. PubMed ID: 15785333
[TBL] [Abstract][Full Text] [Related]
16. Understand the benefits and risks of intraperitoneal therapy for advanced ovarian cancer.
Oestreicher P
ONS Connect; 2007 Apr; 22(4):24-5. PubMed ID: 17477008
[No Abstract] [Full Text] [Related]
17. A modified technique for insertion of intraperitoneal port for chemotherapy.
Liou WS; Teng NN; Chan JK
J Surg Oncol; 2005 Jun; 90(4):247-8. PubMed ID: 15906367
[TBL] [Abstract][Full Text] [Related]
18. Your guide to intraperitoneal chemotherapy.
Eriksson JH; Swenson KK
Oncol Nurs Forum; 1986; 13(5):77-81. PubMed ID: 3638722
[No Abstract] [Full Text] [Related]
19. Intraosseous infusion: a lifesaving technique.
King ML; Moses EC
Nursing; 1990 Jan; 20(1):32K, 32N-32P. PubMed ID: 2300286
[No Abstract] [Full Text] [Related]
20. Injections.
Campbell J
Prof Nurse; 1995 Apr; 10(7):455-8. PubMed ID: 7724637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
